{
    "2021-11-09": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Oklahoma court overturns $465 million opioid ruling against Johnson & Johnson",
                "features": {
                    "keywords": [
                        "Oklahoma",
                        "court",
                        "overturns",
                        "opioid",
                        "ruling",
                        "Johnson & Johnson"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Johnson & Johnson Opioid Verdict Overturned by Oklahoma Supreme Court",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Opioid",
                        "Verdict",
                        "Overturned",
                        "Oklahoma",
                        "Supreme",
                        "Court"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "U.S. administers 433.2 mln doses of COVID-19 vaccines - CDC",
                "features": {
                    "keywords": [
                        "U.S.",
                        "administers",
                        "COVID-19",
                        "vaccines",
                        "CDC"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "public health"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Janssen Partially Terminates Nanoparticle License Agreement With Alkermes",
                "features": {
                    "keywords": [
                        "Janssen",
                        "Partially",
                        "Terminates",
                        "Nanoparticle",
                        "License",
                        "Agreement",
                        "Alkermes"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Why Alkermes Stock Is Sinking Today",
                "features": {
                    "keywords": [
                        "Alkermes",
                        "Stock",
                        "Sinking"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Wave of Solid Q3 Earnings Push Pharma ETFs Higher",
                "features": {
                    "keywords": [
                        "Solid",
                        "Q3",
                        "Earnings",
                        "Pharma",
                        "ETFs",
                        "Higher"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Pulse",
                        "Merck",
                        "Alkermes",
                        "Slips",
                        "Partial",
                        "Termination",
                        "J&J",
                        "Licensing",
                        "Deal",
                        "Amgen",
                        "Migraine",
                        "Drug",
                        "Data"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?",
                "features": {
                    "keywords": [
                        "Invest",
                        "Fidelity",
                        "MSCI",
                        "Health",
                        "Care",
                        "Index",
                        "ETF",
                        "FHLC"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "index funds"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}